Table 3.
Effect of treatment on the control group.
| Outcome | Pretreatment (n = 44) | Posttreatment (n = 40) | p value | ||
|---|---|---|---|---|---|
| Mean ± SD | Median (Q1, Q3) | Mean ± SD | Median (Q1, Q3) | ||
| BDI | 18.84 ± 3.42 | 20.00 (17.00, 22.00) | 15.48 ± 4.18 | 17.00 (12.00, 19.00) | < 0.001b∗ |
| HDRS | 19.64 ± 3.41 | 20.00 (18.00, 22.00) | 14.08 ± 3.77 | 14.00 (11.00, 17.00) | < 0.001b∗ |
| GERD questionnaire | 46.73 ± 5.72 | 46.00 (43.50, 50.50) | 35.54 ± 12.23 | 37.50 (26.00, 44.75) | < 0.001a∗ |
| NPRS | 6.25 ± 0.67 | 6.00 (6.00, 7.00) | 4.95 ± 0.96 | 5.00 (4.00, 6.00) | < 0.001b∗ |
Note: n, number of participants; Q1, first quartile; Q3, third quartile.
Abbreviations: BDI, Beck Depression Inventory; GERD, gastroesophageal reflux disease; HDRS, Hamilton Depression Rating Scale; NPRS, Numerical Pain Rating Scale; SD, standard deviation.
aStudent's t.
bWilcoxon w.
∗Significant value, if p < 0.05.